A unified dyskinesias rating scale for L-dopa-induced dyskinesias?
Affiliations
- PMID: 10493408
Item in Clipboard
A unified dyskinesias rating scale for L-dopa-induced dyskinesias?
Mov Disord.
1999.
No abstract available
Similar articles
-
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.Mov Disord. 1999;14 Suppl 1:13-8. Mov Disord. 1999. PMID: 10493399 Review. No abstract available.
-
Rating scales for dyskinesias in Parkinson's disease.Mov Disord. 1999;14 Suppl 1:48-53. Mov Disord. 1999. PMID: 10493403 Review. No abstract available.
-
[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].Rev Neurol (Paris). 2001 May;157(5):507-14. Rev Neurol (Paris). 2001. PMID: 11438770 French.
-
[Dyskinesia caused by L-DOPA].Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S92-101. Rev Neurol (Paris). 2002. PMID: 12690668 Review. French.
-
[Physiopathology of the dyskinesias induced by L-dopa].Rev Neurol. 1997 Aug;25 Suppl 2:S151-6. Rev Neurol. 1997. PMID: 9280682 Review. Spanish.
Cited by
-
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia.Front Aging Neurosci. 2020 Aug 11;12:230. doi: 10.3389/fnagi.2020.00230. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32848709 Free PMC article.
-
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.Pharmacoeconomics. 2001;19(10):1013-38. doi: 10.2165/00019053-200119100-00004. Pharmacoeconomics. 2001. PMID: 11735671 Review.
-
Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers.J Neurol. 2018 Sep;265(9):2005-2014. doi: 10.1007/s00415-018-8951-3. Epub 2018 Jun 27. J Neurol. 2018. PMID: 29951701